The results of a phase III trial confirm the place of canakinumab in the treatment arsenal for these disorders. Cryopyrin-associated periodic syndromes (CAPS) are a family of related conditions ...
New-onset psychosis in HIV-seropositive patients has prevalence estimates ranging from 0.5 to 15%, [91] and is most often seen in neurocognitive disorders, such as delirium, HIV-associated ...